Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
NewAmsterdam Pharma Company NV banner
N

NewAmsterdam Pharma Company NV
NASDAQ:NAMS

Watchlist Manager
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Watchlist
Price: 29.44 USD -3.79% Market Closed
Market Cap: $3.4B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

NAMS Price Targets Summary
NewAmsterdam Pharma Company NV

Wall Street analysts forecast NAMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAMS is 50.53 USD with a low forecast of 38.38 USD and a high forecast of 63 USD.

NAMS Lowest Forecast
Wall Street Target
38.38 USD
30% Upside
NAMS Average Forecast
Wall Street Target
50.53 USD
72% Upside
NAMS Highest Forecast
Wall Street Target
63 USD
114% Upside
Lowest
Price Target
38.38 USD
30% Upside
Average
Price Target
50.53 USD
72% Upside
Highest
Price Target
63 USD
114% Upside
NewAmsterdam Pharma Company NV Competitors:
Price Targets
LAND
Gladstone Land Corp
-8% Downside
ZNTL
Zentalis Pharmaceuticals Inc
95% Upside
F
FLB
Fluidigm Corp
64% Upside
RYI
Ryerson Holding Corp
48% Upside
LAND
Gladstone Land Corp
-8% Downside
ZNTL
Zentalis Pharmaceuticals Inc
95% Upside
F
FLB
Fluidigm Corp
64% Upside
RYI
Ryerson Holding Corp
48% Upside

Revenue
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of NewAmsterdam Pharma Company NV's revenue for the next 6 years is 28%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
NAMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NAMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NAMS stock valuation using valuation multiples.
Wall Street Estimates
NAMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NAMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NAMS's stock price target?
Price Target
50.53 USD

According to Wall Street analysts, the average 1-year price target for NAMS is 50.53 USD with a low forecast of 38.38 USD and a high forecast of 63 USD.

What is NewAmsterdam Pharma Company NV's Revenue forecast?
Projected CAGR
28%

The compound annual growth rate of NewAmsterdam Pharma Company NV's revenue for the next 6 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 324,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett